글로벌 양막 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

양막은 여성의 태반에서 채취하여 심각한 외상 상처, 화상, 만성 상처 등의 경우에 이식 재료로 사용하는 태아막의 가장 깊은 층입니다. 비용 효율적인 치료법 개발의 기술적 발전으로 인해 양막 시장은 2022년에서 2029년의 예측 기간 동안 상당히 상승할 가능성이 높습니다. 양막 이식의 증가, 양막 이식의 이점에 대한 지식과 교육의 증가, 노령 인구의 증가로 인해 시장이 발전할 것으로 예상됩니다.

Data Bridge Market Research는 2021년에 13억 2,629만 달러였던 양막 시장이 2029년까지 31억 2,320만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 11.30%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

Market Definition

The amniotic membrane, also called the amnion, is the placenta's innermost layer. A thick foundation membrane and an avascular stromal matrix make up this structure. In different surgical specialisations, amniotic membrane transplantation has been used as a graft or as a dressing. In pterygium surgery, amniotic membrane tissue is transplanted after the aberrant tissue on the corneal side is peeled away without injuring the underlying corneal tissue.

Amniotic Membrane Market Dynamics

Drivers

• High incidence of burn wound cases

According to WHO, the majority of burn incidents occur in low- and middle-income countries, with over two-thirds happening in Africa and Southeast-Asia. Because burn wounds are so common, demand for wound care biologics such as amniotic membranes has skyrocketed. In India, one million people suffer from mild to severe burns each year (Source: WHO). Burns are also common in other Southeast Asian nations like Bangladesh and Nepal. The amniotic membrane burn therapy market is growing because it is effective in treating severe burn wounds.

• Rising craze to look flawless

Physical beauty has become one of the most important components of one's personality, and maintaining a faultless appearance is one of today's most popular trends. Amniotic tissues aid in the healing of wounds and burns. In recent years, Indians have embraced a high number of ophthalmology and cosmetic surgical treatments, which is likely to boost the expansion of amniotic membrane product suppliers in the country. Due to an increase in amniotic dry eye therapy, India's market is predicted to grow by double digits. Amniotic membranes are often used as a biological bandage to heal or replace injured eye tissues during eye procedures. The expanding popularity of dry eye amniotic membrane therapy, increased awareness among the general public, increasing amniotic membrane application, and growing popularity of skin care treatments are all likely to boost demand for amniotic goods in the country over the forecast period.

• Dry eye amniotic membrane treatment largely popular in the U.S.

The United States is likely to provide a large amount of revenue, since the country's chronic wound industry offers enormous opportunities for amniotic membrane suppliers. Because of the widespread use of amniotic membrane therapy for dry eye surface concerns has been included in ocular treatments. As a result of the growing number of ophthalmic surgeries performed in the United States as a result of the ageing population, the entire market is expanding significantly.

Opportunities

• Amniotic tissues and amniotic membrane fluid-promising treatment methods

The global amniotic membrane market is expected to be driven by the ageing population, expansion of amniotic membrane transplant indications, increased research and development
(R&D) investments in AMT by key players, increased focus on amniotic tissues cell and stem cell research, unmet clinical needs, regulatory harmonisation, and other factors.

Amniotic tissues and amniotic membrane fluid can be used to treat chronic plantar fasciosis and achilles tendinosis. Amniotic tissues can be used as a skin graft without having to worry about tissue typing or matching the donor to the receiver. As a result, amniotic membranes and amniotic membrane fluid could be used in new allografts and stem cell therapies for degenerative diseases. The ophthalmology market is predicted to increase gradually in the next years, primarily to the increasing use of tissue-based products in ocular treatments due to their speedy recovery properties, such as lowering inflammation and improving healing.

Restraints/Challenges

However, in the forecast period 2022 to 2029, limits on the usage of amniotic membranes and strict government regulations may impede the growth of the Europe amniotic membrane market. AM is now being researched for application in the treatment of cancer, lung injury, and other internal organ damage. Despite the positive results of lung damage treatment, the use of this treatment on patients is still up in the air. Because of the limited use of AM on skin tissues and some external organs, it has come to a halt in other therapies, and more study is undertaken. As a result, it is the only roadblock to AM's usage in medical treatment of chronic disorders in humans.

This amniotic membrane market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the amniotic membrane market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Amniotic Membrane Market

The COVID-19 outbreak had a negative influence on the amniotic goods industry in 2020 due to widespread lockdowns, refused wound care treatments, and cancelled or postponed elective surgeries. Elective operations were rejected (cancelled/postponed) so that scarce capacities and resources (such as hospital beds and patient care professionals) may be allocated or redirected to COVID-19 patient care. Several countries also implemented lockdowns and curfews to combat the rising number of COVID-19 cases. Lockdowns prevented patients from visiting hospitals, outpatient clinics, or clinics. This temporary stoppage of freefone healthcare services is expected to delay the market for amniotic goods. However, demand for amniotic products is expected to rise dramatically in the coming years.

Recent Development

• According to the Europe Transport Safety Council, the number of road deaths per million people in the European Union was 42 in 2020.
• In April 2021, SurgiLogix will debut their SXDBMTM Fiber allograft, which is made completely of demineralized cortical bone and does not require a carrier. When 100 percent demineralized cortical bone is hydrated with any bioactive ingredient, it creates a malleable fibrous structure that can be utilised to fix bony cavities or gaps. It absorbs blood, BMA, or PRP fast and forms a superior osteoconductive scaffold with increased osteoinductive potential.

Global Amniotic Membrane Market Scope

The amniotic membrane market is segmented on the basis of type, product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Cryopreserved
• Lyophilized

Application

• Surgical Wounds
• Ophthalmology
• Others

End-User

• Hospitals
• Specialized Clinics
• Ambulatory Surgical Centres
• Academic Research Centres

Amniotic Membrane Market Regional Analysis/Insights

The amniotic membrane market is analysed and market size insights and trends are provided by country, type, product, application and end-user as referenced above.

The countries covered in the amniotic membrane market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

대체 기술에 대한 관심이 높아지고 현대 기술이 도입되면서 북미 지역이 시장을 장악하고 있으며, 이는 2022년부터 2029년까지의 예측 기간 동안 이 지역의 시장 확대를 촉진할 것으로 예측됩니다.

아시아 태평양 지역은 예측 기간 동안 상당한 CAGR로 성장할 것으로 예상됩니다. 이 지역의 대부분 국가는 경제적으로 성장하고 있으며, 가처분 소득이 증가하고 있으며, 여러 글로벌 기업이 이 지역에 상당한 투자를 했습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다. 

의료 인프라 성장 설치 기반 및 신기술 침투

양막 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 양막 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 양막 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 양막 시장 점유율 분석

양막 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 양막 시장과 관련된 회사의 초점에만 관련이 있습니다.

양막 시장의 주요 업체는 다음과 같습니다.

• 티슈테크 주식회사 (미국)
• 응용생물학(미국)
• LifeLike BioTissue(미국)
• 셀룰라리티 주식회사(미국)
• Labtician Ophthalmics Inc. (캐나다)
• 스미스+네퓨(영국)
• 스트라이커(미국)
• WWW.SURGILOGIX.COM. (미국)
• 인테그라 라이프사이언스(미국)
• MiMedx(미국)
• 스카이 바이오로직스 홀딩스 LLC(미국)
• Amniox Medical Inc(미국)
• 휴먼 리제너레이티브 테크놀로지스 LLC (미국)
• 카테나 프로덕츠 주식회사 (미국)
• Amnio Technology, LLC(미국)

SKU-68484